Lumedica Receives Phase II SBIR-NSF Grant to develop dual-axis optical coherence tomography for deep tissue imaging.
DURHAM, NORTH CAROLINA — Lumedica Inc., a privately held company, [...]
Dr. Adam Wax Publishes Results of First Clinical Study of Low-Cost Retinal OCT
We've known since Lumedica's founding that the low-cost OCT would [...]
Lumedica Pitches Investors at NC Biotech’s CED Conference.
Lumedica was one of a handful of startups that were [...]